DeVita, Seffrin Present Cancer Czar PlanTo Feinstein, Without Committee Sign-Off
Varmus, Branscomb Win Public Service Award From NSF; NCI Clarifies Plans For Large R01s
President’s Cancer Panel: NCI’s Approach “Paying Off,” Thompson Tells Cancer Panel
NCI Clarifies Plan For Review Of Epidemiologic Research
Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial
Oncology Management: US Oncology To Conduct Up To 5 Studies Of PG-TXL In Colorectal, Lung Cancers
Deals & Collaborations: UAB To Evaluate Firm’s Prostate Cancer Treatment
Emerging Technologies: Company To Expand Program Studying Polymer Platinates
Trending Stories
- Preparing to take care of each other in ways we never imagined
- 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- From the chairs of ECOG-ACRIN: A perspective on indirect costs
- On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”
